CERO THERAPEUTICS HOLDINGS, INC. (CERO)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 14, 2025 | CORRESP | Neutral/Informational | Moderate | CERO Therapeutics Holdings, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-3. They are seeking to hav… | Read Filing EDGAR |
| Aug. 14, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to CERO Therapeutics Holdings, Inc. that they will not review the company's registration statement filed on August 11, 2025. The SEC reminds the company t… | Read Filing EDGAR |
| Jul. 28, 2025 | CORRESP | Neutral/Informational | Moderate | CERO Therapeutics Holdings, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to hav… | Read Filing EDGAR |
| Jul. 25, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has notified Cero Therapeutics Holdings, Inc. that it will not review their registration statement filed on July 21, 2025. The letter emphasizes the company's responsibili… | Read Filing EDGAR |
| May. 7, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of CERO Therapeutics Holdings, Inc.'s Preliminary Proxy Statement filed on April 25, 2025. They remind the company and its management of their res… | Read Filing EDGAR |
| May. 2, 2025 | CORRESP | Neutral/Informational | Moderate | CERO Therapeutics Holdings, Inc. submitted a response to the SEC's comments regarding their Preliminary Proxy Statement on Schedule 14A. The correspondence includes revisions made… | Read Filing EDGAR |
| May. 1, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed the Preliminary Proxy Statement on Schedule 14A filed by CERO Therapeutics Holdings, Inc. and has issued comments requiring clarification on two key proposals… | Read Filing EDGAR |